(Q50591200)

16 March 2018

title

Antiviral drugs for common respiratory diseases. What's here, what's to come. (English)

1 reference

16 March 2018

author name string

Johnson DC

series ordinal

1

1 reference

16 March 2018

language of work or name

English

0 references

publication date

1 February 1988

1 reference

16 March 2018

published in

Postgraduate Medicine

1 reference

16 March 2018

volume

83

1 reference

16 March 2018

issue

2

1 reference

16 March 2018

page(s)

136-9, 142-3, 146-8

1 reference

16 March 2018

Properties of antiviral agents. 2

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1988.11700143

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1988.11700143

Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1988.11700143

Antiviral chemotherapy and chemoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1988.11700143

Antiviral agents in influenza--summary of Influenza Workshop VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1988.11700143

Therapeutic effects of aerosolized amantadine in naturally acquired infection due to influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1988.11700143

A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1988.11700143

Ribavirin treatment of experimental respiratory syncytial viral infection. A controlled double-blind study in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1988.11700143

Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1988.11700143

Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1988.11700143

Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1988.11700143

10.1080/00325481.1988.11700143

21 January 2018

Identifiers

DOI

1 reference

16 March 2018

PubMed ID

2448762

1 reference

16 March 2018